Serum C-reactive protein as a predictor of morbidity and mortality in intensive care unit patients after esophagectomy

Annals of Thoracic Surgery

Volumn 91, Issue 6, 2011, Pages 1775-1779

  Van Genderen, Michel E ^a   Lima, Alexandre ^a   De Geus, Hilde ^a   Klijn, Eva ^a   Wijnhoven, Bas ^a   Gommers, Diederik ^a   Van Bommel, Jasper ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; DISEASE ASSOCIATION; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL;

AGED; C-REACTIVE PROTEIN; COHORT STUDIES; ESOPHAGECTOMY; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 79957780692     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.02.042     Document Type: Article

References (30)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340: 448-54. (Pubitemid 29084777)
2. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21(Suppl 2): S258-63.
3. Grander W, Dunser M, Stollenwerk B, et al. C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 2010;138:856-62.
4. Póvoa P, Almeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998;24:1052-6. (Pubitemid 28497823)
5. Zingg U, Forberger J, Rajcic B, Langton C, Jamieson GG. Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer. J Gastrointest Surg 2010;14:462-9.
6. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176:335-8. (Pubitemid 28514444)
7. de Mello J, Struthers L, Turner R, Cooper EH, Giles GR. Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer 1983;48: 341-8. (Pubitemid 13000803)
8. Hefler LA, Concin N, Hofstetter G, et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 2008;14:710-4. (Pubitemid 351231151)
9. Wullstein C, Drognitz O, Woeste G, et al. High levels of C-reactive protein after simultaneous pancreas-kidney transplantation predict pancreas graft-related complications and graft survival. Transplantation 2004;77:60-4. (Pubitemid 38116873)
10. Werner J, Hartwig W, Uhl W, Müller C, Büchler MW. Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003;3:115-27. (Pubitemid 36577072)
11. Ho KM, Dobb GJ, Lee KY, Towler SC, Webb SA. C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. J Crit Care 2006; 21:259-65. (Pubitemid 44380341)
12. Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 2008;34:481-7. (Pubitemid 351623026)
13. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-9. (Pubitemid 36706731)
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
15. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009;136 (5 Suppl):e28.
16. Woeste G, Müller C, Bechstein WO, Wullstein C. Increased serum levels of C-reactive protein precede anastomotic leakage in colorectal surgery. World J Surg 2010;34:140-6.
17. Shimada H, Kitabayashi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24-31. (Pubitemid 36183122)
18. Morita M, Yoshida R, Ikeda K, et al. Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid. Dis Esophagus 2008;21:30-6.
19. Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg 1999;177:78-82. (Pubitemid 29089003)
20. Sakamoto K, Arakawa H, Mita S, et al. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine 1994;6:181-6. (Pubitemid 24263857)
21. Deitmar S, Anthoni C, Palmes D, Haier J, Senninger N, Bruwer M. Are leukocytes and CRP early indicators for anastomotic leakage after esophageal resection? [Article in German]. Zentralbl Chir 2009;134:83-9.
22. Sato Y, Motoyama S, Maruyama K, et al. Extravascular lung water measured using single transpulmonary thermodilution reflects perioperative pulmonary edema induced by esophagectomy. Eur Surg Res 2007;39:7-13. (Pubitemid 46422221)
23. Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002; 236:184-90. (Pubitemid 34809537)
24. Buise M, Van Bommel J, Mehra M, Tilanus HW, Van Zundert A, Gommers D. Pulmonary morbidity following esophagectomy is decreased after introduction of a multimodal anesthetic regimen. Acta Anaesthesiol Belg 2008;59: 257-61.
25. Casado D, López F, Martí R. Perioperative fluid management and major respiratory complications in patients undergoing esophagectomy. Dis Esophagus 2010;23:523-8.
26. Tetteroo GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA. Selective decontamination to reduce Gram-negative colonisation and infections after oesophageal resection. Lancet 1990;335:704-7. (Pubitemid 20089315)
27. Grotenhuis BA, van Hagen P, Reitsma JB, et al. Validation of a nomogram predicting complications after esophagectomy for cancer. Ann Thorac Surg 2010;90:920-5.
28. Lagarde SM, Reitsma JB, Maris AK, et al. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg 2008;85:1938-45.
29. McCulloch P, Ward J, Tekkis PP; ASCOT group of surgeons; British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003;327:1192-7.
30. Pierie JP, de Graaf PW, van Vroonhoven TJ, Obertop H. Healing of the cervical esophagogastrostomy. J Am Coll Surg 1999;188:448-54. (Pubitemid 29162704)